Drugs Of Abuse Panel-12 Drug Panel

The Drugs Of Abuse Panel-12 Drug Panel is a laboratory-grade screening that detects the presence of twelve commonly abused substances and their metabolites, typically from a urine sample. The service uses initial immunoassay screening with laboratory confirmatory testing (GC‑MS or LC‑MS/MS) for positive results, delivering clinically reliable outcomes suitable for medical, occupational, or legal use. This at-home collection option combines convenience with accredited laboratory analysis to ensure accuracy and chain-of-custody where required.

This panel is useful for pre-employment and routine workplace screening, clinical assessment before procedures, monitoring during substance‑use treatment or rehabilitation, and post-incident testing. It is appropriate for adults and organisations across Dubai and the UAE seeking discreet, confidential reporting with fast turnaround times; variant reporting or legally admissible documentation (chain-of-custody) can be arranged when needed.

• Amphetamines
• Methamphetamines
• Benzodiazepines
• Barbiturates
• Cocaine (Benzoylecgonine)
• Marijuana (THC)
• Opiates (Morphine/Codeine)
• Methadone
• Oxycodone
• Buprenorphine
• Phencyclidine (PCP)
• MDMA (Ecstasy)

• Pre-employment or pre-engagement drug screening
• Post-incident or suspected on-duty impairment
• Routine or random workplace testing programmes
• Admission, monitoring, or discharge from substance‑use treatment
• Pre-operative clinical assessment when substance exposure is a concern
• Legal, custody, or forensic testing when documented evidence is required

• Comprehensive coverage of 12 common drugs and metabolites
• Accredited laboratory confirmation for positive screens
• Discreet at‑home sample collection with UAE‑wide service (including Dubai)
• Fast, confidential electronic reporting with optional printed certificates
• Chain‑of‑custody and legally admissible documentation available on request

• Midstream urine sample collected during the home visit
• No fasting required; avoid excessive fluid intake for 2 hours before collection
• Valid photo ID and signed consent required at time of collection
• Notify collector of any prescribed medications or supplements prior to testing